TY  - GEN
AU  - Teng,Y K Onno
AU  - Bruce,Ian N
AU  - Diamond,Betty
AU  - Furie,Richard A
AU  - van Vollenhoven,Ronald F
AU  - Gordon,David
AU  - Groark,James
AU  - Henderson,Robert B
AU  - Oldham,Mary
AU  - Tak,Paul P
TI  - Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol
SN  - 2044-6055
PY  - 2020///0403
KW  - Adult
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Clinical Trials, Phase III as Topic
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Injections, Subcutaneous
KW  - Lupus Erythematosus, Systemic
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Multicenter Studies as Topic
KW  - Prednisone
KW  - Randomized Controlled Trials as Topic
KW  - Rituximab
KW  - Severity of Illness Index
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1136/bmjopen-2018-025687
ER  -